Hassan Souidan, MD, Clinical Neurophysiology Fellow
Hassan Souidan, MD, Clinical Neurophysiology Fellow
Office Address
Wayne State University School of Medicine
Department of Neurology - 8D UHC
4201 St. Antoine
Detroit, MI 48201
Office Phone: (313) 577-1245
Clinic appointments: (313) 745-4275
Narrative Bio
Hassan Souidan, M.D., is a distinguished clinical neurophysiology fellow at Detroit Medical Center-Wayne State University. He completed his adult neurology residency at the same institution, where he demonstrated exceptional leadership as Chief Resident. Dr. Souidan earned his medical degree from the University of Balamand in Lebanon and a Bachelor of Science in Biology from the American University of Beirut.
Dr. Souidan's professional journey is marked by his interest in the field of epilepsy, including a post-doctoral fellowship at the American University of Beirut Medical Center. His scholarly work encompasses numerous publications in reputable journals and presentations at prominent national conferences. He is an active member of the American Academy of Neurology and committed to advancing the field of neurology.
Academic Rank
Clinical Neurophysiology Fellow
Other Information
Dr. Hassan Souidan, MD is a fellow in the Clinical Neurophysiology Program here at the DMC. He recently completed his Residency with the Detroit Medical Center on June 30, 2024.
Undergraduate
BS in Biology, American University of Beirut, Beirut, Lebanon, 2015
Position Title
CNP Fellow in Neurology
Medical
Doctor of Medicine, University of Balamand, Beirut, Lebanon, 2019
Residency
Detroit Medical Center - Wayne State University
Publications
Papers:
1. Arichena Manmatharayan, Rene Andrade-Machado, Rohit Marawar, Paul Lee, Abdalhamid Lagnf, Hassan Souidan, Taha Ataya, Farah Abdelhak, Rohan Thomas, Rami Fakhouri, Younes Motii, Sarah Rehman, Margerie Durban, Dennis Parker, Wazim Mohamed, Mona Elsayed. EEG Patterns Predicting Clobazam Response in Refractory Status Epilepticus in Adults. Journal of Epileptology. July 2024
2. Souidan H, Machado RA, Lagnf A, Elsayed M. Double antiglutamatergic treatment in patients with status epilepticus: A case series. Epilepsy Behav. 2022 Dec. PMID: 36375305.
3. Nadine Kawkabani, Omar Boustros, Rita Farah, Roula Darwish, Moussa Abi Ghanem, Hassan Souidan, Hiba Zeidh, Mohammad Hadi El Charif, Bassam Abou Khalil, Reproducible and Reliable Modified Technique of Surgical Aortic Valve Replacement That Decreases the Incidence of Permanent Pace Maker Implantation, International Journal of Cardiovascular and Thoracic Surgery. Volume 6, Issue 3, May 2020
4. Fares J, Jabbour E, Haidar A, Souidan H, Soboh I, Massaad N, Dandachi I, Moghnieh R, Samaha R, Daoud Z. Analysis of CAST in 9 Lebanese hospitals between 2008 and 2017. J Infect Public Health. 2019 Sep-Oct. PMID: 30904498.
Abstracts & Oral Presentations
1. Hassan Souidan, Taha Ataya, H.S. Danieli, Mona Elsayed. West Nile Neuroinvasive Disease in patients receiving B-cell depleting therapy. Annual Meeting of the Americas Committee on Treatment and Research in Multiple Sclerosis, February 29-March 2, 2024, West Palm Beach, FL.
2. Abdalhamid Lagnf, Hassan Souidan, Abdelrahman M.Alsherbini, Rene Andrade Machado, Mona Elsayed. Focal epilepsy: EEG interictal patterns and etiology correlation. Oral presentation. American Academy of Neurology Annual Meeting April 22-27, 2023. Boston, Massachusetts.
3. Hassan Souidan, Rene Andrade Machado, Abdalhamid Lagnf, Mona Elsayed. Double antiglutamatergic treatment in patients with status epilepticus: A case series. American Academy of Neurology Annual Meeting April 22-27, 2023. Boston, Massachusetts.
4. Arichena Ramanathan Manmatharayan, Rene Andrade Machado, Paul Lee, Abdalhamid Lagnf, Hassan Souidan, Taha Ataya, Farah Abdelhak, Rohan Thomas, Rami Fakhouri, Younes Motii, Margerie Durban, Janaki Patel, Dennis Parker Jr., Cristina Jageka, Wazim Mohamed, Mona Elsayed. Electro-clinical Variables Associated with Clobazam Response in Adults Presenting with Refractory Status Epilepticus: A Retrospective Study. American Academy of Neurology Annual Meeting, April 13-18, 2024. Denver, Colorado.